Micro Cap Growth Fund
Daily price w/o sales charge as of 10/01/2026
$28.93
$0.06
YTD Returns w/o sales charge as of 10/01/2026
19.59%
Overall Morningstar RatingsSmall Growth
as of 08/31/2026
Morningstar rated the Lord Abbett Micro Cap Growth Fund class I share 4, 3 and 5 stars among 521, 499 and 405 Small Growth Funds for the overall rating and the 3, 5 and 10 year periods ended 8/31/2026, respectively.
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
Fund Basicsas of 08/31/2026
- Total Net Assets
- $208.90 M
- Inception Date
- 07/09/1999
- Dividend Frequency
- Annually
- Fund Gross Expense Ratio
- 1.12%
- Fund Net Expense Ratio
- 1.12%
- Number of Holdings
- 86
Fund Expense Ratio :
Gross 1.12%
Net 1.12%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 07/09/1999 |
|---|
| w/o sales charge | 19.84% | 22.64% | 23.53% | 5.37% | 16.05% | 11.78% |
| Lipper Category Avg. Small-Cap Growth Funds | - | - | - | - | - | - |
| Russell Microcap® Growth Index | 8.50% | 10.83% | 23.06% | 2.60% | 8.14% | - |
| w/ sales charge | 19.84% | 22.64% | 23.53% | 5.37% | 16.05% | 11.78% |
Performance data for the Lipper Category Average and for the Index is shown as soon as it becomes available.
Fund Expense Ratio :
Gross 1.12%
Net 1.12%
Fund Expense Ratio :
Gross 1.12%
Net 1.12%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 07/09/1999 |
|---|
| w/o sales charge | 19.84% | 22.64% | 23.53% | 5.37% | 16.05% | 11.78% |
| Lipper Category Avg. Small-Cap Growth Funds | - | - | - | - | - | - |
| Russell Microcap® Growth Index | 8.50% | 10.83% | 23.06% | 2.60% | 8.14% | - |
Performance data for the Lipper Category Average and for the Index is shown as soon as it becomes available.
Fund Expense Ratio :
Gross 1.12%
Net 1.12%
Past performance is not a reliable indicator or guarantee of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost.
TEN LARGEST HOLDINGS as of 08/31/2026View Portfolio
| Holding | Assets |
|---|---|
| Adaptive Biotechnologies Corp | 2.95% |
| Aehr Test Systems | 2.63% |
| Enliven Therapeutics Inc | 2.52% |
| Red Violet Inc | 2.20% |
| CECO Environmental Corp | 2.19% |
| Nurix Therapeutics Inc | 2.03% |
| IMAX Corp | 2.01% |
| MBX Biosciences Inc | 1.96% |
| Lindblad Expeditions Holdings Inc | 1.94% |
| CareDx Inc | 1.90% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 08/31/2026View Portfolio
| Sector | Weighting |
|---|
| Sector | Weighting |
|---|---|
| Communication Services | |
| Real Estate | |
| Utilities | |
| Consumer Discretionary | |
| Consumer Staples | |
| Energy | |
| Financials | |
| Health Care | |
| Industrials | |
| Information Technology | |
| Materials |
INVESTMENT TEAM
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
Gross 1.12%
Net 1.12%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 07/09/1999 |
|---|
| w/o sales charge | 19.84% | 22.64% | 23.53% | 5.37% | 16.05% | 11.78% |
| Lipper Category Avg. Small-Cap Growth Funds | - | - | - | - | - | - |
| Russell Microcap® Growth Index | 8.50% | 10.83% | 23.06% | 2.60% | 8.14% | - |
| w/ sales charge | 19.84% | 22.64% | 23.53% | 5.37% | 16.05% | 11.78% |
Performance data for the Lipper Category Average and for the Index is shown as soon as it becomes available.
Fund Expense Ratio :
Gross 1.12%
Net 1.12%
Fund Expense Ratio :
Gross 1.12%
Net 1.12%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 07/09/1999 |
|---|
| w/o sales charge | 19.84% | 22.64% | 23.53% | 5.37% | 16.05% | 11.78% |
| Lipper Category Avg. Small-Cap Growth Funds | - | - | - | - | - | - |
| Russell Microcap® Growth Index | 8.50% | 10.83% | 23.06% | 2.60% | 8.14% | - |
Performance data for the Lipper Category Average and for the Index is shown as soon as it becomes available.
Fund Expense Ratio :
Gross 1.12%
Net 1.12%
Past performance is not a reliable indicator or guarantee of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost.
| Year | Fund Returns | Russell Microcap® Growth Index |
|---|
| 2025 | 11.02% | 21.84% |
| 2024 | 27.28% | 21.91% |
| 2023 | 6.14% | 9.11% |
| 2022 | -29.10% | -29.76% |
| 2021 | 3.74% | 0.88% |
| 2020 | 79.62% | 40.13% |
| 2019 | 34.56% | 23.33% |
| 2018 | 2.85% | -14.18% |
| 2017 | 38.38% | 16.65% |
| 2016 | 2.05% | 6.86% |
| 2015 | -6.38% | - |
| 2014 | 10.84% | - |
| 2013 | 78.60% | - |
| 2012 | 2.61% | - |
| 2011 | -5.68% | - |
| 2010 | 34.16% | - |
| 2009 | 52.94% | - |
| 2008 | -46.28% | - |
| 2007 | 23.03% | - |
| 2006 | 25.71% | - |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|
| 2026 | 0.25% | 35.26% | -11.62% | - |
| 2025 | -17.85% | 15.92% | 13.93% | 2.33% |
| 2024 | 7.71% | 0.22% | 6.93% | 10.27% |
| 2023 | 5.64% | 4.23% | -13.40% | 11.31% |
| 2022 | -17.19% | -22.51% | 8.29% | 2.02% |
| 2021 | 12.36% | -0.04% | -9.38% | 1.93% |
| 2020 | -24.27% | 47.66% | 17.49% | 36.72% |
| 2019 | 22.62% | 7.46% | -13.89% | 18.59% |
| 2018 | 5.33% | 15.78% | 10.04% | -23.35% |
| 2017 | 8.97% | 8.17% | 13.63% | 3.32% |
| 2016 | -13.66% | 5.93% | 14.56% | -2.61% |
| 2015 | 7.34% | 4.13% | -16.29% | 0.06% |
| 2014 | 7.88% | -6.49% | -6.59% | 17.62% |
| 2013 | 21.81% | 15.05% | 17.29% | 8.65% |
| 2012 | 17.75% | -9.67% | 1.33% | -4.80% |
| 2011 | 4.83% | 0.21% | -21.88% | 14.92% |
| 2010 | 6.71% | -8.76% | 15.18% | 19.64% |
| 2009 | -0.92% | 31.55% | 13.54% | 3.35% |
| 2008 | -23.11% | 4.51% | -5.94% | -28.93% |
| 2007 | 5.67% | 9.88% | 4.11% | 1.78% |
| 2006 | 17.21% | -9.74% | 1.27% | 17.34% |
| 2005 | -9.47% | 5.97% | 6.97% | 0.18% |
| 2004 | 12.41% | 1.71% | -11.01% | 24.04% |
| 2003 | -3.40% | 27.24% | 11.82% | 8.95% |
| 2002 | 0.00% | -12.70% | -21.73% | 1.46% |
| 2001 | 2.44% | 12.12% | -20.98% | 29.33% |
| 2000 | 26.57% | -20.89% | -4.70% | -19.21% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
NAV Historical Prices
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| Adaptive Biotechnologies Corp | Health Care | 2.95% |
| Aehr Test Systems | Information Technology | 2.63% |
| Enliven Therapeutics Inc | Health Care | 2.52% |
| Red Violet Inc | Information Technology | 2.20% |
| CECO Environmental Corp | Industrials | 2.19% |
| Nurix Therapeutics Inc | Health Care | 2.03% |
| IMAX Corp | Communication Services | 2.01% |
| MBX Biosciences Inc | Health Care | 1.96% |
| Lindblad Expeditions Holdings Inc | Consumer Discretionary | 1.94% |
| CareDx Inc | Health Care | 1.90% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| Adaptive Biotechnologies Corp | Health Care | 2.95% |
| Aehr Test Systems | Information Technology | 2.63% |
| Enliven Therapeutics Inc | Health Care | 2.52% |
| Red Violet Inc | Information Technology | 2.20% |
| CECO Environmental Corp | Industrials | 2.19% |
| Nurix Therapeutics Inc | Health Care | 2.03% |
| IMAX Corp | Communication Services | 2.01% |
| MBX Biosciences Inc | Health Care | 1.96% |
| Lindblad Expeditions Holdings Inc | Consumer Discretionary | 1.94% |
| CareDx Inc | Health Care | 1.90% |
| Mama's Creations Inc | Consumer Staples | 1.78% |
| Chefs' Warehouse Inc/The | Consumer Staples | 1.77% |
| Agilysys Inc | Information Technology | 1.77% |
| Transcat Inc | Industrials | 1.72% |
| Pattern Group Inc | Consumer Discretionary | 1.71% |
| Bel Fuse Inc | Information Technology | 1.66% |
| WisdomTree Inc | Financials | 1.60% |
| Forum Energy Technologies Inc | Energy | 1.58% |
| Jade Biosciences Inc | Health Care | 1.53% |
| Navan Inc | Consumer Discretionary | 1.50% |
| Xometry Inc | Industrials | 1.47% |
| Citi Trends Inc | Consumer Discretionary | 1.46% |
| Amplitude Inc | Information Technology | 1.45% |
| Ambiq Micro Inc | Information Technology | 1.45% |
| Neptune Insurance Holdings Inc | Financials | 1.43% |
| Ooma Inc | Information Technology | 1.38% |
| Butterfly Network Inc | Health Care | 1.37% |
| Marex Group Ltd | Financials | 1.32% |
| Via Transportation Inc | Information Technology | 1.28% |
| Unusual Machines Inc /US | Information Technology | 1.25% |
| Miami International Holdings Inc | Financials | 1.23% |
| TAT Technologies Ltd | Industrials | 1.19% |
| uniQure NV | Health Care | 1.19% |
| Vita Coco Co Inc/The | Consumer Staples | 1.19% |
| Navitas Semiconductor Corp | Information Technology | 1.18% |
| Celcuity Inc | Health Care | 1.16% |
| Nektar Therapeutics | Health Care | 1.15% |
| Willdan Group Inc | Industrials | 1.15% |
| Neutron Holdings Inc | Industrials | 1.14% |
| Alamar Biosciences Inc | Health Care | 1.10% |
| Palvella Therapeutics Inc | Health Care | 1.10% |
| Fastly Inc | Information Technology | 1.09% |
| Neogen Corp | Health Care | 1.07% |
| Cardinal Infrastructure Group Inc | Industrials | 1.06% |
| Intapp Inc | Information Technology | 1.06% |
| Backblaze Inc | Information Technology | 1.03% |
| Penguin Solutions Inc | Information Technology | 1.02% |
| BlackSky Technology Inc | Industrials | 1.01% |
| First Tracks Biotherapeutics Inc | Health Care | 0.99% |
| Lincoln Educational Services Corp | Consumer Discretionary | 0.98% |
| Relay Therapeutics Inc | Health Care | 0.97% |
| Helios Technologies Inc | Industrials | 0.95% |
| Rapport Therapeutics Inc | Health Care | 0.95% |
| Ouster Inc | Information Technology | 0.93% |
| Legence Corp | Industrials | 0.92% |
| Target Hospitality Corp | Consumer Discretionary | 0.91% |
| Sphere Entertainment Co | Communication Services | 0.90% |
| MYR Group Inc | Industrials | 0.90% |
| Dave Inc | Financials | 0.86% |
| Innodata Inc | Industrials | 0.86% |
| Newamsterdam Pharma Co NV | Health Care | 0.80% |
| Billiontoone Inc | Health Care | 0.80% |
| HeartFlow Inc | Health Care | 0.79% |
| Cogent Biosciences Inc | Health Care | 0.78% |
| Standex International Corp | Industrials | 0.77% |
| Freenome Inc | Health Care | 0.73% |
| BJ's Restaurants Inc | Consumer Discretionary | 0.73% |
| American Public Education Inc | Consumer Discretionary | 0.72% |
| 908 Devices Inc | Information Technology | 0.64% |
| Warby Parker Inc | Consumer Discretionary | 0.63% |
| Mayville Engineering Co Inc | Industrials | 0.62% |
| Tyra Biosciences Inc | Health Care | 0.62% |
| Flywire Corp | Financials | 0.60% |
| SharonAI Holdings Inc | Information Technology | 0.56% |
| Appian Corp | Information Technology | 0.54% |
| Beta Bionics Inc | Health Care | 0.53% |
| Gilat Satellite Networks Ltd | Information Technology | 0.53% |
| Sezzle Inc | Financials | 0.52% |
| CG oncology Inc | Health Care | 0.52% |
| Cleanspark Inc | Information Technology | 0.46% |
| Extreme Networks Inc | Information Technology | 0.45% |
| Universal Technical Institute Inc | Consumer Discretionary | 0.45% |
| Proto Labs Inc | Industrials | 0.39% |
| Applied Aerospace & Defense Inc | Industrials | 0.35% |
| Vishay Precision Group Inc | Information Technology | 0.26% |
| Liftoff Mobile Inc | Communication Services | 0.20% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 08/31/2026
| Sector | Weighting | Fund Change from Previous Quarter |
|---|
| Sector | Weighting | Fund Change from Previous Quarter |
|---|---|---|
| Communication Services |
0.20%
|
|
| Real Estate | 0.00% | |
| Utilities | 0.00% | |
| Consumer Discretionary |
 1.10%
|
|
| Consumer Staples |
0.90%
|
|
| Energy |
1.50%
|
|
| Financials |
0.20%
|
|
| Health Care |
0.40%
|
|
| Industrials |
7.40%
|
|
| Information Technology |
4.60%
|
|
| Materials | 0.00% |
Portfolio Details as of 08/31/2026
- Total Net Assets
- $208.90 M
- Number of Holdings
- 86
- Weighted Average Market Cap.
- 2.7 B
- P/B Ratio
- 5.0x
- P/E Ratio
- 43.8x
To view definitions for the above Portfolio Details, Click here.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
Dividends & Cap Gains
Dividends & Cap Gains
Dividend Payments
- YTD Dividends Paidas of 10/01/2026
- $0
- Dividend Frequency
- Annually
| Record Date | Ex-Dividend Date | Reinvest & Payable Date | Dividend | Reinvest Price |
|---|---|---|---|---|
| 12/01/2025 | 12/02/2025 | 12/02/2025 | $0.00190 | $24.36 |
Upcoming Dividend Payment Dates
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date | Reinvest & Payable Date |
|---|---|---|
| 11/23/2026 | 11/24/2026 | 11/24/2026 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|---|---|---|---|---|
| 11/23/2020 | 11/24/2020 | $2.8043 | $2.2741 | $5.0784 | $18.90 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Fees & Expenses
Fees & Expenses
Expense Ratioas of 08/31/2026
| Fund Gross Expense Ratio | 1.12% |
| Fund Net Expense Ratio | 1.12% |
Fund Documents
Fund Documents
|
0Documents selected
|
||||
|---|---|---|---|---|
|
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
|
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
|
Summary Prospectus
Publish Date:11/03/2015
|
||||
|
Statutory Prospectus
Publish Date:11/03/2015
|
||||
|
SAI
Publish Date:11/03/2015
|
||||
|
Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
|
2025 Annual Tailored Shareholder Report
Publish Date:11/03/2015
|
||||
|
2026 Semi-Annual Tailored Shareholder Report
Publish Date:11/03/2015
|
||||
|
Semi-Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
|
Fact Sheet
Publish Date:11/03/2015
|